-
DPP-4 inhibitors in the prevention/treatment of pulmonary fibrosis, heart and kidney injury caused by covid-19-a therapeutic approach of choice in type 2 diabetic patients? [Elektronski vir]Smelcerović, Andrija ...Since the outbreak of SARS-CoV-2 virus more than 12,500,000 cases have been reported worldwide. Patients suffering from diabetes and other comorbidities are particularly susceptible to severe forms ... of the COVID-19, which might result in chronic complications following recovery. Dipeptidyl peptidase-4 inhibitors exert beneficial effects in prevention/treatment of pulmonary fibrosis, heart, and kidney injury, and since they may be a long-term consequence caused by COVID-19, it is reasonable to expect that DPP-4 inhibitors might be beneficial in alleviating long-term consequences of COVID-19. With that in mind, we would like to voice our concerns over chronic implications following recovery from COVID-19, especially not only in diabetic but also in non-diabetic patients, and to indicate that some preventive measures could be undertaken by application of DPP-4 inhibitors.Source: Frontiers in pharmacology [Elektronski vir]. - ISSN 1663-9812 (Vol. 11, 2020, str. 1-4)Type of material - e-article ; adult, seriousPublish date - 2020Language - englishCOBISS.SI-ID - 25125123
Author
Smelcerović, Andrija |
Kocić, Gordana |
Gajic, Mihajlo, farmacevt |
Tomović, Katarina |
Djordjevic, Vukica |
Stankovic-Djordjevic, Dobrila |
Anderluh, Marko
Topics
Sladkorna bolezen |
COVID-19 |
diabetes |
DPP-4 inhibitors |
fibrosis |
multi-organ injury |
poškodbe notranjih organov |
korona virus |
DPP-4 zaviralci |
pljučna fibroza
Author | Smelcerović, Andrija ... |
Title | DPP-4 inhibitors in the prevention/treatment of pulmonary fibrosis, heart and kidney injury caused by covid-19-a therapeutic approach of choice in type 2 diabetic patients? [Elektronski vir] |
Publication date | 2020-08-05 |
COBISS.SI-ID | 25125123 |
Publication version in repository | Publisher's version |
Publication licence | Creative Commons Attribution 4.0 International |
Embargo | Immediate publication for public |
Project(s) from which the publication was funded
Title | Acronym | Project ID | Funder |
---|---|---|---|
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin | P1-0208-2015 |
Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije |
Files that belong to the publication
Link |
---|
https://www.frontiersin.org/articles/10.3389/fphar.2020.01185/full |
https://repozitorij.uni-lj.si/IzpisGradiva.php?id=124557 |
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|---|
Smelcerović, Andrija | |
Kocić, Gordana | |
Gajic, Mihajlo, farmacevt | |
Tomović, Katarina | |
Djordjevic, Vukica | |
Stankovic-Djordjevic, Dobrila | |
Anderluh, Marko | 21456 |
Select pickup location:
Material pickup by post
Notification
Subject headings in COBISS General List of Subject Headings
Select pickup location
Pickup location | Material status | Reservation |
---|
Please wait a moment.